이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Assessment of Pain Perception and the Impact of Central Sensitization on Biopsychosocial Manifestations During Physical Activity in Patients With Chronic Low Back Pain (BASICS)

2026년 9월 15일 업데이트: University Hospital, Brest

The goal of this prospective observational study is to evaluate changes in cognitive and behavioural markers associated with central sensitisation between the start and end of an exercise retraining programme on an exercise bike, in adult patients suffering from chronic lower back pain associated with an untreated degenerative spine, worth or without referred pain.

The main changes it will evaluate are:

- Changes in cognitive and behavioural markers associated with central sensitisation between Day 0 and Day 40 during exercise retraining on an exercise bike as part of a rehabilitation programme for chronic low back pain

Participants will undergo the followings:

  • A calibration test used to define moderate exertion on an ergocycle, corresponding to a perceived exertion of 4-5/10 on the modified Borg scale
  • Exercise-induced pain intensity assessment tests to detect changes in the intensity of pain during physical activity and the activity's potential to cause pain, realised on ergocyle
  • Exercise rehabilitation on an ergocycle
  • Final tests to assess cognitive and behavioural markers related to central sensitisation and pain intensity, as at baseline.

연구 개요

상태

아직 모집하지 않음

정황

상세 설명

Patients with chronic low back pain who are scheduled to receive care at the Musculoskeletal Rehabilitation Unit of the Cornouaille Rehabilitation Center in Concarneau for low back pain rehabilitation-either through a group program on a part-time inpatient basis or an individual program on a full-time inpatient basis-will be considered for inclusion in the study.

Eligible patients will be enrolled after the investigator has provided them with comprehensive verbal and written information, conducted initial assessments, verified the inclusion and exclusion criteria, and obtained signed informed consent from the patients. For inpatients, verification of inclusion and exclusion criteria will take place on the day of admission to the Concarneau PRC during the initial evaluation.

Upon admission, the patient is assessed according to standard criteria for the management of patients with low back pain (measurements of spinal mobility: Fingers-to-Floor Distance (FFD), spinal inclinometry in flexion and extension, lateral bending, Schober's test, muscle strength assessment: Shirado and Sorensen tests, measurement of hamstring and quadriceps hyperextensibility), to which are added the Oswestry Questionnaire to assess disability related to low back pain, the CSI questionnaire, which assesses symptoms of central sensitization, and an evaluation of various cognitive-behavioral markers related to central sensitization, including sensitization due to motor disorders (Luomajoki tests), sensitization due to kinesiophobia (Tempa Scale of Kinesiophobia and KINAP), and sensitization due to catastrophizing (Pain Catastrophizing Scale).

After enrollment, patients will undergo a calibration test on an exercise bike on Day 1 to determine the power required to maintain a constant moderate effort corresponding to an intensity of 4-5/10 on the modified Borg scale. Then, to assess the pain-inducing potential of exercise on an ergocycle, they will perform two tests (on Day 3 and Day 5) to evaluate changes in pain during moderate, sustained exercise.

During their rehabilitation for low back pain, patients undergo exercise retraining on an ergocycle. From Day 8 through Day 40 (3 times per week, on Mondays, Wednesdays, and Fridays), the patients' perceived exertion will be assessed at the end of each ergometer session to verify that they are indeed maintaining a constant moderate level of exertion.

Patients will be assessed on Day 40 to collect measurements of cognitive-behavioral markers related to central sensitization and pain intensity, as was done at enrollment.

연구 유형

중재적

등록 (추정된)

40

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

설명

Inclusion Criteria:

  • Adult patients, ages 18 through 75 inclusive, admitted to the Musculoskeletal Rehabilitation Unit at the Concarneau Regional Hospital
  • Chronic low back pain due to degenerative spine disease that has not been treated surgically, with or without referred pain
  • Low back pain intensity of 4/10 or less on the EVA scale
  • Pain lasting more than 12 months (= critical period for cerebral impairment)
  • Oswestry score between 21% and 40%
  • CSI score of 33/100 or higher for women and 25/100 or higher for men
  • Patients enrolled in or covered by a social security program
  • Patients who have signed a consent form

Exclusion Criteria:

  • Patients with acute low back pain of traumatic or neoplastic origin
  • Patients with a contraindication to moderate-intensity physical activity (Borg 4-5/10 on the modified Borg scale)
  • Inability to participate in sessions due to pain unrelated to low back pain or a disability
  • Pregnant or breastfeeding patients
  • Patients under legal guardianship or conservatorship

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 다른
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
다른: Exercise rehabilitation on an ergocycle

Following enrolment, patients will undergo a calibration test on an ergocycle on Day 1 to determine the power required to maintain a constant moderate effort corresponding to an intensity of 4-5/10 on the modified Borg scale. Then, to assess the pain-inducing potential of exercise on the ergocycle, they will undertake two tests (on Day 3 and Day 5) to evaluate changes in pain during constant moderate exertion.

During their rehabilitation programme for low back pain, patients will undergo exercise retraining on the ergocycle. From Day 8 to Day 40 (three times a week, on Mondays, Wednesdays and Fridays), the patients' perception of exertion will be assessed at the end of each exercise bike session to ensure that they are maintaining a constant moderate level of exertion.

Patients will be assessed on Day 40 to collect data on cognitive and behavioural markers related to central sensitisation and pain intensity, as at baseline.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change in Luomajoki tests score
기간: Baseline and Day 40
The Luomajoki test consists of six movement control tests assessing lumbar movement control. The score is calculated as the number of positive tests and ranges from 0 to 6. Higher score is worse outcome.
Baseline and Day 40
Change in Tampa Scale of Kinesiophobia
기간: Baseline and Day 40
The Tampa Scale of Kinesiophobia is a questionnaire used to assess kinesiophobia, defined as the fear of movement. It consists of 17 items, each rated on a 4-point scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). The score is calculated as the sum of the 17 items and ranges from 17 to 68. Higher score is worse outcome.
Baseline and Day 40
Change in KINAP score
기간: Baseline and Day 40
The KINAP consists of presenting participants with photographs illustrating physical and sports activities. For each photograph, participants are asked to rate, on a scale from 0% to 100%, the intensity of their fear regarding potential negative consequences (e.g., pain). The total score is calculated as the mean of the ratings provided for all photographs and ranges from 0% to 100%. Higher scores indicate greater fear and represent a worse outcome.
Baseline and Day 40
Change in Pain catastrophizing scale
기간: Baseline and Day 40
The Pain Catastrophizing Scale is used to assess the tendency to exaggerate the threat of pain, ruminate about pain, and experience feelings of helplessness in relation to pain. It consists of 13 items, each rated from 0 ("not at all") to 4 ("all the time"). The total score is calculated as the sum of the scores of the 13 items and ranges from 0 to 52 Higher score is worse outcome.
Baseline and Day 40

2차 결과 측정

결과 측정
측정값 설명
기간
Pain score
기간: Day 3, before cycle ergometer test initiation
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, before cycle ergometer test initiation
Pain score
기간: Day 3, 3 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 3 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 6 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 6 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 9 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 9 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 12 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 12 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 15 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 15 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 18 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 18 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 21 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 21 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 24 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 24 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 27 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 27 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 3, 30 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 3, 30 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, before cycle ergometer test initiation
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, before cycle ergometer test initiation
Pain score
기간: Day 5, 3 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 3 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 6 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 6 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 9 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 9 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 12 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 12 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 15 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 15 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 21 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 21 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 24 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 24 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 27 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 27 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Day 5, 30 minutes after cycle ergometer test initiation, if applicable
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Day 5, 30 minutes after cycle ergometer test initiation, if applicable
Pain score
기간: Baseline
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Baseline
Luomajoki tests score
기간: Baseline
The Luomajoki test consists of six movement control tests assessing lumbar movement control. The score is calculated as the number of positive tests and ranges from 0 to 6. Higher score is worse outcome.
Baseline
Tampa Scale of Kinesiophobia
기간: Baseline
The Tampa Scale of Kinesiophobia is a questionnaire used to assess kinesiophobia, defined as the fear of movement. It consists of 17 items, each rated on a 4-point scale ranging from 1 ("strongly disagree") to 4 ("strongly agree"). The score is calculated as the sum of the 17 items and ranges from 17 to 68. Higher score is worse outcome.
Baseline
KINAP score
기간: Baseline
The KINAP consists of presenting participants with photographs illustrating physical and sports activities. For each photograph, participants are asked to rate, on a scale from 0% to 100%, the intensity of their fear regarding potential negative consequences (e.g., pain). The total score is calculated as the mean of the ratings provided for all photographs and ranges from 0% to 100%. Higher scores indicate greater fear and represent a worse outcome.
Baseline
Pain catastrophizing scale
기간: Baseline
The Pain Catastrophizing Scale is used to assess the tendency to exaggerate the threat of pain, ruminate about pain, and experience feelings of helplessness in relation to pain. It consists of 13 items, each rated from 0 ("not at all") to 4 ("all the time"). The total score is calculated as the sum of the scores of the 13 items and ranges from 0 to 52 Higher score is worse outcome.
Baseline
Change in pain score
기간: Baseline and Day 40
Pain score will be measured using visual analogic scale. Score goes from 0 cm to 10 cm. Higher score is worse outcome.
Baseline and Day 40

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 9월 20일

기본 완료 (추정된)

2028년 4월 30일

연구 완료 (추정된)

2028년 4월 30일

연구 등록 날짜

최초 제출

2026년 9월 8일

QC 기준을 충족하는 최초 제출

2026년 9월 8일

처음 게시됨 (실제)

2026년 9월 14일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 18일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 15일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • 29BRC24.0293 - BASICS

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다